LRN
BULLISH
$95.16
Live
Stride, Inc. · NYSE
Target $113.5
(+19.3%)
$60.61
52W Range
$171.17
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 30, 2026
Market cap
$4.05B
P/E
14.89
ROE
22.3%
Profit margin
12.7%
Debt/Equity
0.36
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
85%
LRN exhibits a stable financial profile with a Piotroski F-Score of 6/9 and exceptional liquidity, evidenced by a current ratio of 7.27. While the current price of $95.16 trades at a slight premium to the Graham Number ($72.77) and Intrinsic Value ($86.9), the valuation remains highly attractive with a PEG ratio of 0.51 and a forward P/E of 10.81. Strong profitability metrics, including an ROE of 22.26%, combined with a consistent track record of earnings beats, outweigh the current bearish technical trend. The company is fundamentally undervalued relative to its growth and efficiency.
Key Strengths
Exceptional liquidity with a current ratio of 7.27 and quick ratio of 6.79
Very low leverage with a Debt/Equity ratio of 0.36
Strong profitability with ROE at 22.26% and ROA at 13.23%
Highly attractive valuation indicated by a PEG ratio of 0.51
Consistent earnings performance with 3 of the last 4 quarters beating estimates
Key Risks
Bearish technical trend (0/100) suggesting short-term price pressure
Current price is trading above the Graham and Intrinsic value baselines
Modest revenue growth (7.5% YoY) compared to high-growth sector peers
Lack of dividend yield provides no floor for income-oriented investors
Significant volatility as seen in the 52-week range ($60.61 - $171.17)
AI Fair Value Estimate
Based on comprehensive analysis
$89.5
-5.9% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
63
Strong
85
60
80
90
0
AI Verdict
Strong Fundamental Value
Key drivers: Low PEG ratio, High ROE, Extreme liquidity, Low Debt/Equity
Confidence
90%
Value
85/100
Ref P/E, PEG, Graham Number
Positives
- P/E of 14.89 is well below sector average of 37.25
- PEG ratio of 0.51 suggests significant undervaluation
Watchpoints
- Price is ~31% above Graham Number
Future
60/100
Ref Growth rates
Positives
- Steady YoY revenue growth of 7.5%
- Positive earnings growth trajectory
Watchpoints
- Growth rates are modest, not explosive
Past
80/100
Ref Historical trends
Positives
- Strong 5Y change of +232.4%
- Consistent history of earnings surprises
Watchpoints
- Poor 1Y performance (-33.3%)
Health
90/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 6/9 (Stable)
- Debt/Equity of 0.36 is very conservative
Watchpoints
- Altman Z-Score not provided
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- No dividend payments
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$95.16
Analyst Target
$113.5
Upside/Downside
+19.3%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for LRN and closest competitors.
Updated 2026-04-29
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
LRN
Stride, Inc.
Primary
|
+232.4% | +122.2% | -33.3% | +35.9% | +13.1% | -6.7% |
|
AKO-A
Embotelladora Andina S.A.
Peer
|
+189.5% | +160.4% | +65.7% | +30.5% | +7.4% | +4.3% |
|
ELF
e.l.f. Beauty, Inc.
Peer
|
+118.5% | -28.3% | +9.3% | -46.0% | -4.8% | -0.8% |
|
CVSA
Covista Inc.
Peer
|
+177.1% | +165.2% | +3.0% | -29.6% | -7.2% | -8.7% |
|
ATGE
Adtalem Global Education Inc.
Peer
|
+211.0% | +215.3% | +20.9% | +5.3% | +17.0% | +3.8% |
LRN
Stride, Inc.
Primary
5Y
+232.4%
3Y
+122.2%
1Y
-33.3%
6M
+35.9%
1M
+13.1%
1W
-6.7%
AKO
Embotelladora Andina S.A.
Peer
5Y
+189.5%
3Y
+160.4%
1Y
+65.7%
6M
+30.5%
1M
+7.4%
1W
+4.3%
ELF
e.l.f. Beauty, Inc.
Peer
5Y
+118.5%
3Y
-28.3%
1Y
+9.3%
6M
-46.0%
1M
-4.8%
1W
-0.8%
CVS
Covista Inc.
Peer
5Y
+177.1%
3Y
+165.2%
1Y
+3.0%
6M
-29.6%
1M
-7.2%
1W
-8.7%
ATG
Adtalem Global Education Inc.
Peer
5Y
+211.0%
3Y
+215.3%
1Y
+20.9%
6M
+5.3%
1M
+17.0%
1W
+3.8%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
14.89
Forward P/E
10.81
PEG Ratio
0.51
P/B Ratio
2.58
P/S Ratio
1.61
EV/Revenue
1.52
EV/EBITDA
7.38
Market Cap
$4.05B
Profitability
Profit margins and return metrics
Profit Margin
12.66%
Operating Margin
23.5%
Gross Margin
39.3%
ROE
22.26%
ROA
13.23%
Growth
Revenue and earnings growth rates
Revenue Growth
+7.5%
Earnings Growth
+4.4%
Q/Q Revenue Growth
+7.5%
Q/Q Earnings Growth
+3.2%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.36
Low debt
Current Ratio
7.27
Strong
Quick Ratio
6.79
Excellent
Cash/Share
$14.89
Quarterly Earnings History
EPS performance vs analyst estimates
2026-08-04
$N/A
2026-04-28
$2.3
+4.1% surprise
2026-01-27
$2.5
+7.8% surprise
2025-10-28
$1.52
+20.4% surprise
Consumer Defensive Sector Comparison
Comparing LRN against 185 companies in the Consumer Defensive sector
(10 bullish, 66 neutral, 109 bearish)
P/E Ratio
14.89
This Stock
vs
36.87
Sector Avg
-59.6%
(Discount)
Return on Equity (ROE)
22.26%
This Stock
vs
-12.24%
Sector Avg
-281.9%
(Below Avg)
Profit Margin
12.66%
This Stock
vs
-7.91%
Sector Avg
-260.1%
(Weaker)
Debt to Equity
0.36
This Stock
vs
1.85
Sector Avg
-80.6%
(Less Debt)
Revenue Growth
7.5%
This Stock
vs
103.21%
Sector Avg
-92.7%
(Slower)
Current Ratio
7.27
This Stock
vs
2.28
Sector Avg
+219.1%
(Stronger)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
LRN
Stride, Inc.
|
BULLISH | $4.05B | 14.89 | 22.3% | 12.7% | $95.16 | |
|
AKO-A
Embotelladora Andina S.A.
|
BEARISH | $4.16B | 13.1 | 24.7% | 7.9% | $24.5 | Compare |
|
ELF
e.l.f. Beauty, Inc.
|
NEUTRAL | $3.91B | 37.45 | -0.3% | -0.2% | $66.28 | Compare |
|
CVSA
Covista Inc.
|
NEUTRAL | $3.71B | 15.85 | 18.0% | 13.4% | $107.63 | Compare |
|
ATGE
Adtalem Global Education Inc.
|
NEUTRAL | $4.41B | 18.6 | 17.4% | 13.8% | $121.28 | Compare |
LRN
Stride, Inc.
BULLISH
Mkt Cap
$4.0B
P/E
14.9
ROE
22.3%
Price
$95.16
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-19 | RHYU JAMES JEAHO | Chief Executive Officer | Gift | 1,350 | - |
| 2025-12-04 | FINK STEVEN B | Director | Stock Award | 4,097 | - |
| 2025-12-04 | KNOWLING ROBERT E JR | Director | Stock Award | 4,097 | - |
| 2025-12-04 | ALVAREZ AIDA M | Director | Stock Award | 4,097 | - |
| 2025-12-04 | MCFADDEN ELIZA | Director | Stock Award | 4,097 | - |
| 2025-11-19 | RHYU JAMES JEAHO | Chief Executive Officer | Gift | 25,177 | - |
RHYU JAMES JEAHO
Chief Executive Officer
2026-02-19
1,350 shares
FINK STEVEN B
Director
2025-12-04
4,097 shares
KNOWLING ROBERT E JR
Director
2025-12-04
4,097 shares
ALVAREZ AIDA M
Director
2025-12-04
4,097 shares
MCFADDEN ELIZA
Director
2025-12-04
4,097 shares
RHYU JAMES JEAHO
Chief Executive Officer
2025-11-19
25,177 shares
Insider transactions can signal confidence or concerns about company prospects
SEC Filings
Recent regulatory filings from the SEC EDGAR database
10-Q
10-Q
8-K
8-K
10-Q
DEF 14A
Data sourced from SEC EDGAR. AI summaries generated automatically.
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
NONE
2 analysts
Barrington Research
2026-04-16
Outperform
Outperform
Canaccord Genuity
2026-01-28
Buy
Buy
Barrington Research
2026-01-28
Outperform
Outperform
Barrington Research
2026-01-21
Outperform
Outperform
Morgan Stanley
2025-12-17
Equal-Weight
Equal-Weight
BMO Capital
2025-11-07
Market Perform
Market Perform
Past News Coverage
Recent headlines mentioning LRN from our newsroom.
Newest → oldest
No matching news yet.